DNTH compared with COGT: revenue, margins and what each company keeps, and the suppliers and customers both name

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

COGTCogent Biosciences, Inc.

Mkt capRevenueRevenue

Compare

DNTHDianthus Therapeutics, Inc.

COGTCogent Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DNTH

1 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26±8.9%▼−3.26%×0.37

Aug 5 '26±9.7%▲+1.90%×0.20

May 6 '26±7.6%▲+0.20%×0.03

Mar 9 '26±11.9%▲+21.52%×1.81

COGT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 10 '26±9.6%▼−2.03%×0.21

May 5 '26±9.5%▲+0.68%×0.07

= impliedDNTH realized, solidCOGT realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

Feb 17 '26

±7.5%

▲+2.98%

×0.40

Nov 3 '25±37.0%▼−4.91%×0.13

DNTHDianthus Therapeutics, Inc.

83.12· pre 83.12· delayed

Mkt cap$4.8BRevenue$1MQ3 FY26Revenue$6MFY24

COGTCogent Biosciences, Inc.

29.54· pre 29.21· delayed

Pre-marketNov 5 '26delayed

Mkt cap$5.1BRevenue—Revenue—

Compare

Pre-marketNov 5 '26delayed

DNTHDianthus Therapeutics, Inc.

COGTCogent Biosciences, Inc.

83.12pre 83.12delayed

Price

29.54pre 29.21delayed

$4.8B

Mkt cap

$5.1B

Q3 FY26$1M

Revenue

—

FY24$6M

Revenue

—

DNTH83.12vsCOGT29.54Pre-marketNov 5 '26delayed